Showing results (81-90 of 157) with videos related to
Sort By:
Pageof 16
Plos One|October 3, 2012
Sphingosine kinase 1 is required for mesothelioma cell proliferation: role of histone acetylationSatish Kalari, Nagabhushan Moolky, Srikanth Pendyala, et al.International Journal of Cancer|August 16, 2014
Tumor genome analysis includes germline genome: are we ready for surprises?Daniel V T Catenacci, Andrea L Amico, Sarah M Nielsen, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 24, 2024
The International Association for the Study of Lung Cancer Mesothelioma Staging Project: Proposals for the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Pleural MesotheliomaHedy L Kindler, Adam Rosenthal, Dorothy J Giroux, et al.Lung Cancer (Amsterdam, Netherlands)|July 27, 2012
Cediranib in patients with malignant mesothelioma: a phase II trial of the University of Chicago Phase II ConsortiumNicholas P Campbell, Rangesh Kunnavakkam, Natasha Leighl, et al.Cancer|April 12, 2023
Surgical phenotype of patients with peritoneal mesothelioma and a germline mutationYaniv Berger, Meghana Gadiraju, Ankit Dhiman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2007
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 studyLeonard B Saltz, Heinz-Josef Lenz, Hedy L Kindler, et al.Pancreas|September 22, 2015
A Phase I Study of FOLFIRINOX Plus IPI-926, a Hedgehog Pathway Inhibitor, for Advanced Pancreatic AdenocarcinomaAndrew H Ko, Noelle LoConte, Margaret A Tempero, et al.Journal for Immunotherapy of Cancer|June 22, 2022
Antibody and T cell responses to COVID-19 vaccination in patients receiving anticancer therapiesSherin Juliet Rouhani, Jovian Yu, Daniel Olson, et al.Cancer Biology & Therapy|January 6, 2018
Focal adhesion kinase a potential therapeutic target for pancreatic cancer and malignant pleural mesotheliomaRajani Kanteti, Tamara Mirzapoiazova, Jacob J Riehm, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 15, 2009
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesotheliomaLee M Krug, Harvey I Pass, Valerie W Rusch, et al.Pageof 16